The what, when and how of stereotactic ablative body radiotherapy for oligometastatic prostate cancer

被引：0
|
作者：
Dreosti, Marcus [1 ]
机构：
[1] GenesisCare, Adelaide, SA, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [31] STEREOTACTIC ABLATIVE RADIOTHERAPY IN OLIGOMETASTATIC GYNAECOLOGICAL MALIGNANCIES
    El-Modir, A.
    Zarkar, A.
    Ghafoor, Q.
    Good, J.
    Sherriff, J.
    Yahya, S.
    Watkins, S.
    Karanam, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A103 - A103
  • [32] TWO SEQUENTIAL PILOT STUDIES: STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC BREAST CANCER (BOSTON) AND STEREOTACTIC ABLATIVE RADIOTHERAPY plus PEMBROLIZUMAB FOR OLIGOMETASTATIC BREAST CANCER (BOSTON II)
    David, Steven
    Siva, Shankar
    Bressel, Mathias
    Savas, Peter
    Foroudi, Farshad
    Loi, Sherene
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 167 - 167
  • [33] Stereotactic Ablative Body Radiotherapy for Lung Cancer
    Franks, K. N.
    Jain, P.
    Snee, M. P.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
  • [34] Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy is not feasible
    Lee, T. H.
    Kim, I. A.
    Kim, J.
    Song, C.
    Kim, Y. B.
    Kim, K.
    No, J. H.
    Suh, D. H.
    Chung, J.
    Eom, K.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1067 - S1067
  • [35] STEREOTACTIC ABLATIVE RADIOTHERAPY: A PROMISING CHANCE FOR OLIGOMETASTATIC BREAST CANCER PATIENTS
    Anselmo, Paola
    Arcidiacono, Fabio
    Casale, Michelina
    Nunzi, Martina
    Sabatini, Silvia
    Foglietta, Jenifer
    Italiani, Marco
    Trippa, Fabio
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S722 - S723
  • [36] Tumor Control Probability Modeling and Systematic Review of Oligometastatic Prostate Cancer Treated with Stereotactic Ablative Radiotherapy
    Koerner, S. A.
    Wang, H.
    Olson, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E225 - E226
  • [37] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [38] Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)
    Cheung, P.
    Morton, G.
    Chung, H. T.
    Vesprini, D.
    Chu, W.
    Liu, S. K.
    Tseng, C. L.
    Sahgal, A.
    Soliman, H.
    Myrehaug, S. D.
    Szumacher, E.
    Chung, P.
    Helou, J.
    Emmenegger, U.
    Erler, D.
    Mamedov, A.
    Chan, S.
    Zhang, L.
    Loblaw, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E269 - E270
  • [39] Stereotactic Body Radiotherapy (SBRT) for the Treatment of oligometastatic Prostate Carcinoma
    Sage, E. K.
    Vogel, M. M. E.
    Dewes, S.
    Devecka, M.
    Eiber, M.
    Gschwend, J. E.
    Combs, S. E.
    Schiller, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S160 - S161
  • [40] Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
    David, Steven
    Tan, Jennifer
    Savas, Peter
    Bressel, Mathias
    Kelly, Dianne
    Foroudi, Farshad
    Loi, Sherene
    Siva, Shankar
    BREAST, 2020, 49 : 55 - 62
12345